Pharmaceutical Pellets Market by Technology (Extrusion, Fluid Bed Granulation, Dry Powder Layering, Solution & Suspension Layering, Spray Congealing, and Spray Drying), and by Mechanism of Action (Diffusion, Erosion, and Osmosis) - Global Opportunity Analysis and Industry Forecast, 2020-2027
|
A02626
|
Pages: NA
|
Jul 2020 |
2546 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Pharmaceutical Pellets Market
Request Now !Pellets are free flowing units, which are filled in capsules and formed by agglomeration technique. In agglomeration techniques, fine powder is taken, which is transformed into fine granules. These pellets offer several advantages such as multiple drug delivery in a single dose, masks taste of anxious drugs and thus improve patient compliance for drug administration over other dosage forms.
In addition, pharmaceutical pellets have varied application in pharmaceutical industries such as they improve aesthetic appearance of drugs and compatible for chemically incompatible drugs.
Factors such as rise in life threatening diseases (such as coronary artery diseases, hypertension, stroke, and high cholesterol) and prevalence of chronic diseases (cancers, respiratory diseases, systemic diseases, and kidney diseases) drive the market growth. In addition, increase in healthcare infrastructure and increased patient acceptance of drugs has improved due to innovation of pharmaceutical pellets fuel the growth of the pharmaceutical pellets market.
However, high manufacturing cost and dearth of skilled professionals restrain the market. Increase in R&D in the field of pharmaceutical industry is anticipated to create new opportunities during the forecast period.
The pharmaceutical pellets market is segmented on the basis of technology, mechanism of action, and geography. By technology, it is categorized into extrusion, fluid bed granulation, dry powder layering, solution & suspension layering, spray congealing, and spray drying. By mechanism of action, the market is classified into diffusion, erosion, and osmosis. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
- The study provides an in-depth analysis of the pharmaceutical pellets market, with current trends and future estimations to elucidate the investment pockets.
- Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
- The report offers a quantitative analysis to assist the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis of different segments facilitates to determine various products available in the market.
- Key players are profiled and their strategies are analyzed thoroughly to predict the competitive market outlook.
Pharmaceutical Pellets Market Key Segments:
By Technology
- Extrusion
- Fluid Bed Granulation
- Dry Powder Layering
- Solution & Suspension Layering
- Spray Congealing
- Spray Drying
By Mechanism of Action
- Diffusion
- Erosion
- Osmosis
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
List of players profiled in the report
- Thexa Pharma (P) Limited
- Chemit.in.
- Rainbow Health Care Products
- Pharmaceuticals Private Limited
- U.K. Vet Chem.
- Nami Pharma.
- Abbott Laboratories
- Avanscure Lifesciences Private Limited
- Lograns Pharma Private Limited
- Concord Drugs Limited
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 PHARAMACEUTICAL PELLETS MARKET, BY TECHNOLOGY
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. EXTRUSION
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. FLUID BED GRANULATION
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. DRY POWDER LAYERING
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. SOLUTION & SUSPENSION LAYERING
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. SPRAY-CONGEALING
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. SPRAY DRYING
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
CHAPTER 5 PHARAMACEUTICAL PELLETS MARKET, BY MECHANISM OF ACTION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. DIFFUSION
5.2.1. Market size and forecast
5.3. EROSION
5.3.1. Market size and forecast
5.4. OSMOSIS
5.4.1. Market size and forecast
CHAPTER 6 PHARAMACEUTICAL PELLETS MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Pharamaceutical Pellets Market by Technology
6.2.5. North America Pharamaceutical Pellets Market by Mechanism of Action
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe Pharamaceutical Pellets Market by Technology
6.3.5. Europe Pharamaceutical Pellets Market by Mechanism of Action
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. China market size and forecast
6.4.3.2. Japan market size and forecast
6.4.3.3. India market size and forecast
6.4.3.4. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Pharamaceutical Pellets Market by Technology
6.4.5. Asia-Pacific Pharamaceutical Pellets Market by Mechanism of Action
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. LatinAmerica market size and forecast
6.5.3.2. Middle East market size and forecast
6.5.3.3. Africa market size and forecast
6.5.4. LAMEA Pharamaceutical Pellets Market by Technology
6.5.5. LAMEA Pharamaceutical Pellets Market by Mechanism of Action
CHAPTER 7 COMPANY PROFILES
7.1. THEXA PHARMA (P) LIMITED
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. CHEMIT.IN.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. RAINBOW HEALTH CARE PRODUCTS
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. PHARMACEUTICALS PRIVATE LIMITED
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. U.K. VET CHEM.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. NAMI PHARMA.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. ABBOTT LABORATORIES
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. AVANSCURE LIFESCIENCES PRIVATE LIMITED
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. LOGRANS PHARMA PRIVATE LIMITED
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. CONCORD DRUGS LIMITED
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Pharmaceutical Pellets Market- Global Opportunity Analysis and Industry Forecast, 2020-2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.